治疗充血性心力衰竭药物的开发与临床应用  

Development and Clinical Application of Novel Agents for Treating Congestive Heart Failure

作　　者：刘艺[1] 丁雁[1] 王尔华[1] 

机构地区：[1]中国药科大学医药化工研究所,江苏南京210009

出　　处：《药学进展》2002年第6期334-338,共5页Progress in Pharmaceutical Sciences

摘　　要：充血性心力衰竭 (CHF)是最常见的心血管病死亡原因之一。本文分类介绍国外近期开发的一些较有前途的治疗 CHF新药 。Congestive heart failure(CHF) is one of the main causes of death from cardiac diseases. In the article,the promising therapeutic agents developed recently for CHF were introduced in accordance with their classification,including their acting mechanism and clinical application

关 键 词：充血性心力衰竭 CHF 内皮素受体拮抗剂 多重血管肽酶抑制剂 血管紧张素Ⅱ受体拮抗剂 正性肌力药 

分 类 号：R969[医药卫生—药理学]